Literature DB >> 6351070

Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division.

D W Shen, F X Real, A B DeLeo, L J Old, P A Marks, R A Rifkind.   

Abstract

Inducer-mediated murine erythroleukemia cell (MELC) differentiation provides a model for examining factors determining terminal cell differentiation. The nuclear protein, p53, has been implicated as a potential determinant of cell cycle progression and cell differentiation. In this study p53 content and synthesis, during inducer-mediated MELC differentiation, has been examined with monoclonal antibodies to p53. A decrease in p53 synthesis and content was demonstrated during induced differentiation. As determined by cell cycle fractionation, the decrease in p53 is manifest at all stages of the cell cycle. Hemin, which induces globin mRNA accumulation but not terminal cell division, fails to decrease p53 content. A MELC variant resistant to inducer-mediated commitment to terminal cell division also fails to decrease p53 levels in response to inducers. These experiments suggest that p53 is implicated in MELC cell proliferation and that an induced decrease in p53 may be responsible for G1 phase prolongation and terminal G1 arrest.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6351070      PMCID: PMC390188          DOI: 10.1073/pnas.80.19.5919

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Identification of a transformation-specific protein induced by a Rous sarcoma virus.

Authors:  G Jay; R P Shiu; F T Jay; A S Levine; I Pastan
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

3.  Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.

Authors:  E Fibach; R C Reuben; R A Rifkind; P A Marks
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

4.  Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation.

Authors:  R Gambari; M Terada; A Bank; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 5.  Erythroleukemic differentiation.

Authors:  P A Marks; R A Rifkind
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

6.  Correlation between synthesis of ribosomal RNA and stimulation of DNA synthesis in mouse salivary glands.

Authors:  A M Novi; R Baserga
Journal:  Lab Invest       Date:  1972-05       Impact factor: 5.662

7.  Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation.

Authors:  M Terada; J Fried; U Nudel; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

8.  Induction of globin mRNA accumulation by hemin in cultured erythroleukemic cells.

Authors:  J Ross; D Sautner
Journal:  Cell       Date:  1976-08       Impact factor: 41.582

9.  Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.

Authors:  M Oren; W Maltzman; A J Levine
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

10.  Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells.

Authors:  U Nudel; J E Salmon; M Terada; A Bank; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  13 in total

1.  Metaplastic change in mesenchymal stem cells induced by activated ras oncogene.

Authors:  C Y Tzen; M Filipak; R E Scott
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

2.  Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation.

Authors:  B Rovinski; D Munroe; J Peacock; M Mowat; A Bernstein; S Benchimol
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation.

Authors:  V M Richon; N Weich; L Leng; H Kiyokawa; L Ngo; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.

Authors:  S Schuetze; R Paul; B C Gliniak; D Kabat
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

5.  n-Butyrate mediated inhibition of papovavirus DNA replication in vivo and in cell culture: a mechanistic approach.

Authors:  F F Shadan; L P Villarreal
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

6.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage.

Authors:  A Samad; R B Carroll
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

7.  The gene and the pseudogene for mouse p53 cellular tumor antigen are located on different chromosomes.

Authors:  H H Czosnek; B Bienz; D Givol; R Zakut-Houri; D D Pravtcheva; F H Ruddle; M Oren
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

8.  n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses.

Authors:  F F Shadan; L M Cowsert; L P Villarreal
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.

Authors:  R G Ramsay; K Ikeda; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gastric cancer cells during differentiation induced by traditional Chinese medicines.

Authors:  S Q Gu; Y Y Liang; L R Fan; B Y Li; D S Wang
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.